spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  gastric ulcer 

 HSMN NewsFeed - 27 Mar 2020
Cipla Receives Final Approval for Generic Version of AstraZeneca Pharmaceutical's Nexium(R) (Esomeprazole for Oral Suspension 10mg, 20mg and 40mg)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 10 Aug 2018
Nuvo Pharmaceuticals(TM) Announces Letter of Intent to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 18 Jun 2018
Mallinckrodt Reports Interim Findings Of H.P. Acthar(R) Gel (Repository Corticotropin Injection) Studies
Biopharmaceuticals
 HSMN NewsFeed - 13 Mar 2018
Exalenz Bioscience’s BreathID(R) Hp & BreathID Hp Lab Systems Receive FDA Clearance for Diagnosis of Helicobacter pylori Testing in Pediatric Patients
Diagnostics FDA
 HSMN NewsFeed - 14 Nov 2016
First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar(R) Gel for Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 28 Mar 2016
Aralez Announces FDA Acceptance of New Drug Application for YOSPRALA(TM)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 1 Jun 2015
POZEN Announces Retirement of Founder, Chairman and CEO Dr. John R. Plachetka; Adrian Adams Named as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Nov 2013
Horizon Pharma Announces Agreement to Acquire U.S. Rights to VIMOVO(R) and Provides 2014 Guidance
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 22 Mar 2012
POZEN Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of PA32540
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 12 Jul 2011
POZEN Announces Tomas S. Bocanegra, M.D. as Head of Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Apr 2011
Horizon Pharma Announces FDA Approval of DUEXIS(R) (ibuprofen/famotidine) for the Relief of the Signs and Symptoms of Rheumatoid Arthritis and Osteoarthritis and to Decrease the Risk of Developing Upper Gastrointestinal Ulcers
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Feb 2011
POZEN Announces Addition to Commercial Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 May 2010
Logical Therapeutics Secures $16.9M Series C Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 May 2010
FDA Approved VIMOVO(TM) for Arthritis Patients at Risk of Developing NSAID-Associated Gastric Ulcers
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 14 Sep 2009
POZEN Names Elizabeth A. Cermak as Executive Vice President, Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 May 2009
AstraZeneca Secures Approval for Nexium (esomeprazole) In Peptic Ulcer Bleeding
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 11 May 2009
Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 May 2009
AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
Biopharmaceuticals
 HSMN NewsFeed - 29 Jan 2009
POZEN Informed by FDA That Endoscopic Gastric Ulcer Incidence Continues to Be an Acceptable Primary Endpoint
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Jan 2009
IMPAX Receives Final FDA Approval for Omeprazole 40 mg Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 6 Jan 2009
Horizon Therapeutics Announces Senior Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jul 2008
Ranbaxy Launches Omeprazole 40 mg Capsules
Biopharmaceuticals Generics
 HSMN NewsFeed - 28 May 2008
Santarus Announces Development Program for New ZEGERID Prescription Product
Biopharmaceuticals
 HSMN NewsFeed - 28 Feb 2008
Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel
Biopharmaceuticals Litigation
 HSMN NewsFeed - 19 Feb 2008
Santarus Announces Launch of ZEGERID Products by GlaxoSmithKline in Puerto Rico and U.S. Virgin Islands
Biopharmaceuticals
 HSMN NewsFeed - 15 Jan 2008
POZEN Submits Human Lymphocyte Study for Treximet(TM) (Formerly Known as Trexima(TM))
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Nov 2007
Pozen Announces Trexima(TM) (Sumatriptan Succinate and Naproxen Sodium) Amended Response Accepted for Review by FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Oct 2007
POZEN Submits Response to Approvable Letter for Trexima(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Oct 2007
POZEN Plans to Submit Response to Approvable Letter For Trexima(TM) Within the Next Ten Days
Biopharmaceuticals
 HSMN NewsFeed - 19 Sep 2007
New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
Biopharmaceuticals
 HSMN NewsFeed - 7 May 2007
Axcan Announces the U.S. Launch of PYLERA, an Innovative 3-in-1 Capsule Triple Therapy for the Eradication of Helicobacter Pylori
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 28 Feb 2007
Salix Pharmaceuticals Acquires PEPCID(R) Oral Suspension
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 10 Jan 2007
POZEN Names Gilda M. Thomas as Senior Vice President and General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2007
Horizon Therapeutics Announces Special Protocol Assessment With FDA for Phase 3 Trial Program
Biopharmaceuticals
 HSMN NewsFeed - 13 Dec 2006
Pozen Expects to Submit Revised Response to Trexima(TM) (Sumatriptan/Naproxen Sodium) Approvable Letter by Year End
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Nov 2006
POZEN Submits Full Response to FDA Approvable Letter For Trexima(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Oct 2006
Santarus Licenses OTC Rights to Lower Dosage Immediate-Release ZEGERID Products to Schering-Plough
Biopharmaceuticals Licensing
 HSMN NewsFeed - 12 Oct 2006
FDA Approves NEXIUM for the Treatment of Zollinger-Ellison Syndrome
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 17 Sep 2006
Women More Likely to Stay on Once-Monthly Boniva(R) Versus Once-Weekly Osteoporosis Medicines
Biopharmaceuticals
 HSMN NewsFeed - 2 Aug 2006
POZEN and AstraZeneca Announce Global Collaboration to Co-Develop and Commercialize Fixed Dose Combinations of Naproxen and Esomeprazole for the Treatment of Pain
Biopharmaceuticals
 HSMN NewsFeed - 22 May 2006
Study Investigates NEXIUM(R) Benefits Patients With Zollinger-Ellison Syndrome
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 28 Mar 2006
Santarus Announces U.S. Launch of ZEGERID Capsules
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 27 Mar 2006
Santarus Receives FDA Approval for ZEGERID with Magnesium Hydroxide Chewable Tablets
Biopharmaceuticals FDA Gastroenterology
 HSMN NewsFeed - 22 Mar 2006
NEXIUM(R) Shown to Reduce Gastric Ulcers in At-Risk Patients Using Long-Term NSAIDs
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 27 Feb 2006
Santarus Receives FDA Approval for ZEGERID Capsules
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 23 Jan 2006
Santarus Announces Publication of Peer-Reviewed Journal Articles on ZEGERID in Treating Upper GI Diseases and Disorders
Biopharmaceuticals Gastroenterology
Return to NewsFeed  

 Additional items found! 31

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 31 additional stories matching:
gastric ulcer
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.